Clinical Trials Browser

Phase 2 × Melanoma × Bortezomib × Clear all

NCT00288041 2013-03-05

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT00024011 2013-01-16

PS-341 in Treating Patients With Metastatic Malignant Melanoma

Phase 2 Completed

Melanoma